Showing results (411-420 of 974) with videos related to

Sort By:
Pageof 98
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Development, Review, and Activation of Thoracic Oncology Investigator-Initiated TrialsDavid E Gerber, Claire R Wynters, Tanushree Prasad, et al.
Journal for Immunotherapy of Cancer|December 9, 2021
Humoral and cellular correlates of a novel immune-related adverse event and its treatmentAmrit S Gonugunta, Mitchell S von Itzstein, Hong Mu-Mosley, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2025
Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical TrialYuanyuan Zhang, Aaron M Laine, Puneeth Iyengar, et al.
Head & Neck|February 14, 2019
Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profilingSaad A Khan, Bo Ci, Yang Xie, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2015
Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation TrialKenneth D Westover, Billy W Loo, David E Gerber, et al.
BMJ Open|February 26, 2026
Applications of artificial intelligence for real-world evidence generation: a protocol for a living scoping reviewTheodora Oikonomidi, Hanaya Raad, John Diaz-Decaro, et al.
Neuro-Oncology|August 1, 2019
Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastomaGao Guo, Ke Gong, Vineshkumar Thidil Puliyappadamba, et al.
Clinical Chemistry and Laboratory Medicine|October 26, 2022
Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control studyAntigona Ulndreaj, Davor Brinc, Mehmet Altan, et al.
The Oncologist|March 14, 2020
Late-Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor-Induced Raynaud's-Like PhenomenonShaheen Khan, Mitchell S von Itzstein, Rong Lu, et al.
Pediatric Blood & Cancer|September 12, 2025
Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid TumorsMatthew E Campbell, Sonja Stutzman, Sharon Primeaux, et al.
Pageof 98